Cytokeratin 7 Antikörper (N-Term)
-
- Target Alle Cytokeratin 7 (KRT7) Antikörper anzeigen
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
-
Bindungsspezifität
- AA 22-38, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cytokeratin 7 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Anti-Cytokeratin 7
- Spezifität
- Cytokeratin 7
- Immunogen
- Peptide derived from N-terminal sequence of human cytokeratin 7. Antibody recognizes the epitope between Ala22 - Ser38.
- Klon
- R17-S
- Isotyp
- IgG
- Top Product
- Discover our top product KRT7 Primärantikörper
-
-
- Applikationshinweise
- Ready to use antibody dilution. Directly use for application
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- +4˚C, Do not freeze!
-
- Target
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
- Andere Bezeichnung
- Cytokeratin 7 (KRT7 Produkte)
- Hintergrund
- Low molecular weight cytokeratin. Its expression is restricted to the epithelia and theirs neoplasms. Overexpression of CK7 had been detected in the majority of epithelial carcinomas. It is successfully used in detection of renal cell carcinomas, ovarian metastatic carcinomas and in discriminating the primary pulmonary adenocarcinoma from metastatic adenocarcinoma.
- UniProt
- P08729
-